000 01868 a2200517 4500
005 20250512095258.0
264 0 _c19710422
008 197104s 0 0 eng d
022 _a0021-972X
024 7 _a10.1210/jcem-32-4-522
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSherins, R J
245 0 0 _aPituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol).
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cApr 1971
300 _a522-31 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _a17-Ketosteroids
_xblood
650 0 4 _aAdult
650 0 4 _aAndrogens
_xbiosynthesis
650 0 4 _aAndrostanes
_xblood
650 0 4 _aAntimetabolites
_xpharmacology
650 0 4 _aChorionic Gonadotropin
_xpharmacology
650 0 4 _aClinical Trials as Topic
650 0 4 _aClomiphene
650 0 4 _aDehydroepiandrosterone
_xblood
650 0 4 _aDepression, Chemical
650 0 4 _aFeedback
650 0 4 _aFollicle Stimulating Hormone
_xurine
650 0 4 _aGonadotropins, Pituitary
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHypothalamo-Hypophyseal System
_xphysiology
650 0 4 _aLeydig Cells
_xdrug effects
650 0 4 _aLuteinizing Hormone
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOxazoles
_xpharmacology
650 0 4 _aPituitary Function Tests
650 0 4 _aPituitary Gland
_xdrug effects
650 0 4 _aPregnanes
_xpharmacology
650 0 4 _aTestosterone
_xblood
700 1 _aGandy, H M
700 1 _aThorslund, T W
700 1 _aPaulsen, C A
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 32
_gno. 4
_gp. 522-31
856 4 0 _uhttps://doi.org/10.1210/jcem-32-4-522
_zAvailable from publisher's website
999 _c4256355
_d4256355